This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kadish, A. Articles by Mehra, M. Search for Related Content PubMed PubMed Citation Articles by Kadish, A. Articles by Mehra, M. Related Collections Ablation/ICD/surgery Arrhythmias, clinical electrophysiology, drugs

(Circulation. 2005;111:3327-3335.)
© 2005 American Heart Association, Inc.

New Drugs and Technologies

Heart Failure Devices

Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy

Alan Kadish, MD; Mandeep Mehra, MD

From the Division of Cardiology and Bluhm Cardiovascular Institute, Feinberg School of Medicine, Chicago, Ill (A.K.), and the Division of Cardiology, University of Mayland, Baltimore (M.M.).

Correspondence to Alan Kadish, MD, 251 E Huron, Suite 8-536, Chicago, IL 60611. E-mail a-kadish@northwestern.edu

Key Words: death, sudden • defibrillation • electrophysiology • tachyarrhythmias

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
Although the age-adjusted mortality from heart disease has declined in the United States, cardiovascular disease remains the No. 1 cause of death.^1,2 Patients with cardiac disease generally die of one of 2 causes: sudden, unexpected cardiac death or progressive heart failure. Chronic heart failure (CHF) has become an epidemic in the United States. Implantable cardioverter-defibrillator (ICD) therapy has had a major impact on the treatment of heart failure in the United States. The ICD has been shown to decrease mortality relative to the best medical therapy in patients who have survived an episode of sustained ventricular tachycardia (VT) or ventricular fibrillation (VF).³ Unfortunately, only a small minority of patients who experience an out-of-hospital cardiac arrest in the United States are successfully resuscitated.⁴ Thus, ICD therapy has been applied for the primary prevention of sudden death in patients at high risk of cardiac arrest. Once thought to be a "bystander" curiosity in the progression of heart failure, electrical-conduction disturbances are now recognized to be important causes of left ventricular (LV) dysfunction. Cardiac resynchronization therapy (CRT) can restore more-normal electrical contraction and, when combined with defibrillation (CRTD), can have a major impact on the mortality and morbidity of heart failure. Although there remain many limitations and challenges to the appropriate application of ICDs or CRTD, there is no question that device therapy has had a major impact on the management of patients with LV dysfunction.

	ICD Therapy

 
The ICD was developed in the 1970s as a device to detect and automatically terminate ventricular tachyarrhythmias.^5,6 . . . [Full Text of this Article]

This article has been cited by other articles:

				M. Gheorghiade, G. Sopko, L. De Luca, E. J. Velazquez, J. D. Parker, P. F. Binkley, Z. Sadowski, K. S. Golba, D. L. Prior, J. L. Rouleau, et al. Navigating the Crossroads of Coronary Artery Disease and Heart Failure Circulation, September 12, 2006; 114(11): 1202 - 1213. [Full Text] [PDF]

				O.-A. Breithardt and G. Breithardt Quest for the Best Candidate: How Much Imaging Do We Need Before Prescribing Cardiac Resynchronization Therapy? Circulation, February 21, 2006; 113(7): 926 - 928. [Full Text] [PDF]

				Writing Committee, ESC Guidelines on the Diagnosis, K. Swedberg, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, O. Smiseth, and L. Tavazzi The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology: Guidelines for the Diagnosis and Treatment of Chronic Heart Failure: reply Eur. Heart J., November 2, 2005; 26(22): 2473 - 2474. [Full Text] [PDF]